GeoVax

United States
Clermont, Florida, United States, 30080

Company profile

GeoVax company profile

GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). It was founded in 1988 and is based in Smyrna, Georgia, United States.

Business identity

Contact email
[email protected]
Phone number
6783847281
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
1988-01-01, Year

Headquarters

Postal code
30080
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
12
Total equity funding
$84.1M
Last funding
Post IPO Equity / $2.5M / 2025-09-30
Last equity funding
Post IPO Equity / $2.5M
Investors
1
Founders
1
Articles
77
Exited on
1999-04-09

Founders and investors

Founders

Harriet L. Robinson

Investors

U.S. Department of Defense